Uscom Limited (UCM.AX)
AUD 0.03
(0.0%)
AUD 0.03
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -2.07 Million AUD | 19.92% |
| 2023 | -2.59 Million AUD | -31.36% |
| 2022 | -1.97 Million AUD | -113.4% |
| 2021 | -924.24 Thousand AUD | 30.58% |
| 2020 | -1.33 Million AUD | 4.18% |
| 2019 | -1.38 Million AUD | 29.15% |
| 2018 | -1.96 Million AUD | -8.89% |
| 2017 | -1.8 Million AUD | 5.96% |
| 2016 | -1.91 Million AUD | -57.53% |
| 2015 | -1.21 Million AUD | 20.05% |
| 2014 | -1.52 Million AUD | -10.85% |
| 2013 | -1.37 Million AUD | 24.82% |
| 2012 | -1.82 Million AUD | 32.07% |
| 2011 | -2.68 Million AUD | -52.81% |
| 2010 | -1.75 Million AUD | -59.8% |
| 2009 | -1.09 Million AUD | 49.42% |
| 2008 | -2.17 Million AUD | 31.98% |
| 2007 | -3.19 Million AUD | 5.26% |
| 2006 | -3.37 Million AUD | -32.53% |
| 2005 | -2.54 Million AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -900.66 Thousand AUD | 0.0% |
| 2024 Q4 | -1.17 Million AUD | 0.0% |
| 2024 FY | -2.07 Million AUD | 19.92% |
| 2023 FY | -2.59 Million AUD | -31.36% |
| 2023 Q4 | -1.19 Million AUD | 0.0% |
| 2023 Q2 | -1.39 Million AUD | 0.0% |
| 2022 Q4 | -1.02 Million AUD | 0.0% |
| 2022 FY | -1.97 Million AUD | -113.4% |
| 2022 Q2 | -943.29 Thousand AUD | 0.0% |
| 2021 Q2 | -269.66 Thousand AUD | 0.0% |
| 2021 Q4 | -654.58 Thousand AUD | 0.0% |
| 2021 FY | -924.24 Thousand AUD | 30.58% |
| 2020 FY | -1.33 Million AUD | 4.18% |
| 2020 Q4 | 165.01 Thousand AUD | 0.0% |
| 2020 Q2 | -1.49 Million AUD | 0.0% |
| 2019 FY | -1.38 Million AUD | 29.15% |
| 2019 Q4 | -631.42 Thousand AUD | 0.0% |
| 2019 Q2 | -757.97 Thousand AUD | 0.0% |
| 2018 Q4 | -876.5 Thousand AUD | 0.0% |
| 2018 FY | -1.96 Million AUD | -8.89% |
| 2018 Q2 | -1.08 Million AUD | 0.0% |
| 2017 Q2 | -846.17 Thousand AUD | 0.0% |
| 2017 Q4 | -954.67 Thousand AUD | 0.0% |
| 2017 FY | -1.8 Million AUD | 5.96% |
| 2016 FY | -1.91 Million AUD | -57.53% |
| 2016 Q4 | -1.07 Million AUD | 0.0% |
| 2016 Q2 | -837.12 Thousand AUD | 0.0% |
| 2015 FY | -1.21 Million AUD | 20.05% |
| 2015 Q2 | -391.3 Thousand AUD | 0.0% |
| 2015 Q4 | -824.34 Thousand AUD | 0.0% |
| 2014 Q1 | -342.92 Thousand AUD | 51.04% |
| 2014 FY | -1.52 Million AUD | -10.85% |
| 2014 Q4 | -871.42 Thousand AUD | -129.25% |
| 2014 Q3 | -380.12 Thousand AUD | 41.44% |
| 2014 Q2 | -649.07 Thousand AUD | -89.28% |
| 2013 FY | -1.37 Million AUD | 24.82% |
| 2013 Q4 | -700.46 Thousand AUD | -104.26% |
| 2013 Q3 | -342.92 Thousand AUD | 0.0% |
| 2013 Q2 | -342.92 Thousand AUD | 24.82% |
| 2013 Q1 | -456.13 Thousand AUD | 0.0% |
| 2012 Q3 | -456.13 Thousand AUD | 0.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 FY | -1.82 Million AUD | 32.07% |
| 2012 Q1 | -671.47 Thousand AUD | 0.0% |
| 2012 Q2 | -456.13 Thousand AUD | 32.07% |
| 2011 Q2 | -671.47 Thousand AUD | -52.81% |
| 2011 Q4 | - AUD | 100.0% |
| 2011 FY | -2.68 Million AUD | -52.81% |
| 2011 Q1 | -439.41 Thousand AUD | 0.0% |
| 2011 Q3 | -671.47 Thousand AUD | 0.0% |
| 2010 FY | -1.75 Million AUD | -59.8% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -439.41 Thousand AUD | 0.0% |
| 2010 Q1 | -274.97 Thousand AUD | 0.0% |
| 2010 Q2 | -439.41 Thousand AUD | -59.8% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 FY | -1.09 Million AUD | 49.42% |
| 2009 Q2 | -274.97 Thousand AUD | 49.42% |
| 2009 Q3 | -274.97 Thousand AUD | 0.0% |
| 2009 Q1 | -543.62 Thousand AUD | 0.0% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 Q3 | -543.62 Thousand AUD | 0.0% |
| 2008 FY | -2.17 Million AUD | 31.98% |
| 2008 Q1 | -799.2 Thousand AUD | 0.0% |
| 2008 Q2 | -543.62 Thousand AUD | 31.98% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 FY | -3.19 Million AUD | 5.26% |
| 2007 Q3 | -799.2 Thousand AUD | 0.0% |
| 2007 Q2 | -799.2 Thousand AUD | 5.26% |
| 2007 Q1 | -843.55 Thousand AUD | 0.0% |
| 2006 FY | -3.37 Million AUD | -32.53% |
| 2006 Q2 | -843.55 Thousand AUD | -32.53% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q3 | -843.55 Thousand AUD | 0.0% |
| 2006 Q1 | -636.47 Thousand AUD | 0.0% |
| 2005 FY | -2.54 Million AUD | 0.0% |
| 2005 Q2 | -636.47 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | 100.0% |
| 2005 Q3 | -636.47 Thousand AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2003 Q2 | - AUD | 0.0% |
| 2003 Q3 | - AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 94.233% |
| Adherium Limited | -10.22 Million AUD | 79.707% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 78.717% |
| Atomo Diagnostics Limited | -6.84 Million AUD | 69.702% |
| Anteris Technologies Ltd | -67.33 Million AUD | 96.919% |
| Control Bionics Limited | -5.91 Million AUD | 64.917% |
| CardieX Limited | -6.76 Million AUD | 69.333% |
| Compumedics Limited | -338 Thousand AUD | -513.831% |
| Cochlear Limited | 356.8 Million AUD | 100.581% |
| CleanSpace Holdings Limited | -3.12 Million AUD | 33.653% |
| Cyclopharm Limited | -4.7 Million AUD | 55.864% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | 23.991% |
| Nova Eye Medical Limited | -8.79 Million AUD | 76.396% |
| HeraMED Limited | -6.78 Million AUD | 69.416% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 90.83% |
| ImpediMed Limited | -19.79 Million AUD | 89.516% |
| InhaleRx Limited | -1.44 Million AUD | -43.753% |
| LBT Innovations Limited | -3.74 Million AUD | 44.525% |
| Micro-X Limited | -9.76 Million AUD | 78.753% |
| Neurotech International Limited | -5.06 Million AUD | 59.072% |
| OncoSil Medical Limited | -11.91 Million AUD | 82.585% |
| PolyNovo Limited | 5.26 Million AUD | 139.436% |
| Respiri Limited | -7.12 Million AUD | 70.898% |
| SomnoMed Limited | -12.24 Million AUD | 83.052% |
| Universal Biosensors, Inc. | -6.74 Million AUD | 69.225% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | 59.024% |